Avalo Therapeutics (AVTX)'s 30-day implied volatility (IV30) was 70.6% at the close on November 20, 2026, down from 73.8% the day before, against a 52-week range of 53.6% to 400.0%. Its 20-day historical volatility was 94.5%.
Data as of November 20, 2026.